People Behind the Science Podcast Stories from Scientists about Science, Life, Research, and Science Careers

Dr. Wes Gilson is Artificial Intelligence Lead for North America at Siemens Healthineers. Wes and his colleagues use artificial intelligence in the context of healthcare to gain insights on how to improve treatments for patients and how to improve the ways in which clinicians can deliver care. Wes is trained in medical imaging, and he looks at healthcare data in different ways to learn how they can improve healthcare outcomes and help patients recover faster. When he's not at work, Wes enjoys quality time with his two teenage daughters. He also spends his free time traveling, exploring the outdoors, hiking, camping, and playing sports like soccer, basketball, and tennis. Recently, Wes has been taking scuba lessons with the goal of diving on the Great Barrier Reef off the coast of Australia. He was awarded his B.S. in biomedical engineering from Vanderbilt University and his Ph.D. in biomedical engineering and medical imaging from the University of Virginia. Afterwards, Wes conducted postdoctoral research at Johns Hopkins University before joining the team at Siemens. In our interview, Wes will tell us more about his life and science.

Dr. Robert Dudley is President and CEO at Clarus Therapeutics, Inc. and is a clinical pharmacologist and board-certified toxicologist. With a background in clinical pharmacology and toxicology, Bob has dedicated his career to developing new drugs to promote men's health. Over the years, Bob has worked on developing a variety of testosterone products, including the first testosterone gel and an oral testosterone replacement drug. Outside science, Bob and his wife enjoy building new houses together because they love being involved in choosing the details and design of their home. Some of Bob's other hobbies include reading, golfing, and cycling. Riding his bike along the scenic trails in Tennessee is a great way to enjoy quiet time, think, and get exercise. Bob received his B.S. degree in biology from Pepperdine University, his M.S. in biology from the University of New Mexico, and his PhD in Pharmacology and Toxicology from the University of Kansas School of Medicine. Prior to founding Clarus Therapeutics, Bob served as the President, Chief Executive Officer and Director of Anagen Therapeutics, a University of Chicago affiliated company. He has also previously served as President & CEO of Unimed Pharmaceuticals a public company that became a subsidiary of Solvay Pharmaceuticals. He started his career in the pharmaceutical industry at Abbott Laboratories. In our interview, Bob shares more about his life and science.

Dr. Mariana Byndloss is Assistant Professor of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center. Research in Mariana's lab investigates how the bacteria that live inside our gut can affect our health. She is interested in how things like diet, antibiotics, or infection may change how our body behaves. This, in turn, can change how the bacteria in our gut behave and lead to disease. Mariana loves animals, and she spends a lot of her free time with her dog and new puppy. They are both German Shorthair Pointers, and she trains them to hunt and to participate in American Kennel Club competitions. Mariana also enjoys quality time with her husband and son, listening to live music, and exploring all the great restaurants in Nashville. Mariana earned her DVM, MSc in veterinary pathology, and PhD in veterinary pathology from the Universidade Federal de Minas Gerais (UFMG) in Brazil. She was awarded the Brazilian National Prize for best PhD thesis in Veterinary Medicine. Afterwards, Mariana conducted postdoctoral research at the University of California, Davis before joining the faculty at Vanderbilt University Medical Center. In our interview, Mariana will tell us more about her life and science.

Dr. Dylan Edwards is Director of the Moss Rehabilitation Research Institute as well as an Institute Scientist and Director of the Human Motor Recovery Laboratory there. In addition, he is Professor of Neuroscience at Edith Cowan University in Australia, and Faculty at Harvard Medical Schools Continuing medical education program in Transcranial Magnetic Stimulation. In his research, Dylan studies the recovery of movement following damage to the nervous system that may occur after stroke or spinal cord injury. He and his team use rehabilitation robots to assess and train motor function. They also apply noninvasive stimulation to test the circuitry of the nervous system and as an experimental treatment to augment function. When he's not at work, you can find Dylan hanging out with his family, enjoying fantastic food, playing the guitar, observing nature, traveling, and thinking about the future of technology and human civilization. He stays active through running and hitting the waves at his favorite surfing destinations around the world. Dylan received a B.App.Sci. degree with a focus in exercise physiology from Edith Cowan University in Australia and a B.S. degree in Physical Therapy from Curtin University of Technology in Australia. He was awarded his PhD in clinical neurophysiology at the Centre for Neuromuscular and Neurological Disorders at the University of Western Australia (now the Perron Institute for Neurological and Translational Sciences), and he conducted postdoctoral research there afterwards. Prior to joining the team at MRRI, Dylan served as Director of the Non-Invasive Brain Stimulation Laboratory at Burke Neurological Institute, and was Associate Professor of Clinical Neurophysiology at Weill Cornell Medicine in New York.

Dr. Ada Tang is a physical therapist, an Associate Professor in the School of Rehabilitation Science at McMaster University, and a Clinician-Scientist with the Ontario Heart and Stroke Foundation. We know that exercise is an important part of healthy living for everyone, but it can be more difficult for people with stroke to exercise as a result of mobility problems and other factors. Unfortunately, exercise is typically not a strong focus in stroke rehabilitation. Ada and her research team are assessing the impacts of exercise on the cardiovascular health of people with stroke, as well as other populations, and they are working to develop safe and effective exercise programs for people with stroke. Sport and exercise have always been important in Ada's life. In addition to studying exercise in the lab, Ada loves being active outdoors. She spends her free time hiking, enjoying nature, and traveling. Ada is also an avid sports fan, and she enjoys watching sporting events, particularly basketball games with the Toronto Raptors. Ada completed her BSc in Physical Therapy, MSc in Rehabilitation Science, and PhD in Medical Science from the University of Toronto. Afterwards, she was awarded a Canadian Institutes of Health Research Fellowship and conducted postdoctoral research at the University of British Columbia before joining the faculty at McMaster University. In our interview, Ada shares more about her life and science.

Dr. Ana Luisa Trejos is an Associate Professor of Electrical and Computer Engineering as well as Biomedical Engineering at Western University in Canada. She is also an Associate Scientist at the Lawson Health Research Institute. Ana Luisa's research is in the area of mechatronic systems engineering. This field combines mechanical, electrical, computer, and software engineering to develop smart machines that can perceive what is happening in the environment and react intelligently. In particular, she is designing wearable mechatronic technologies that can help people recover from mobility problems due to a musculoskeletal injury or a movement disorder like Parkinson's disease. Her goal is to make these technology solutions more comfortable for users and to restore mobility and quality of life for people with upper body movement impairments. When she's not at work, Ana Luisa enjoys hanging out with her family, reading, putting together jigsaw puzzles, hiking, swimming, running, and renovating her house. Ana Luisa was awarded her B.Sc. degree in mechanical engineering from the University of Costa Rica and her M.A.Sc. in mechanical engineering from the University of British Columbia. She worked as an Applications Engineer for Progressive Moulded Products in Ontario from 2000-2003. She then joined the team at Canadian Surgical Technologies & Advanced Robotics at Western University as a research engineer. Ana Luisa later attended graduate school at Western University where she was awarded her Ph.D. degree in electrical and computer engineering in 2012. Ana Luisa has been awarded the IEEE London Section Outstanding Women in Engineering Award and the For Inspiration and Recognition of Science and Technology (FIRST) Canada District Volunteer Appreciation Award. In our interview, Ana Luisa shares more about her life and research.

Dr. Tim Behrens is Senior Vice President of Human Genetics at the biotech company Maze Therapeutics and Adjunct Professor of Medicine in Rheumatology at the Medical College of Wisconsin. In his research, Tim is working to apply lessons and insights from human genetics to develop new drugs for different diseases. For example, Tim and the team at Maze Therapeutics are working on developing a drug that activates the immune system in new ways to fight cancer. Tim is an avid outdoors enthusiast, so he loves spending his free time canoeing, fishing, and going on wilderness trips. He also enjoys spending time playing the guitar, hanging out with his wife and two children, and playing fetch with the family dogs. Tim received his B.S. in biology from the University of Illinois at Urbana-Champaign and his M.D. from Southern Illinois University School of Medicine. He completed his residency in Internal Medicine and a fellowship in Rheumatology/Immunology at the Medical College of Wisconsin. Afterwards, Tim worked as an emergency room physician at Brookfield Memorial Hospital in Wisconsin for about a year before accepting a postdoctoral fellowship at the National Cancer Institute of the National Institutes of Health. Tim joined the faculty at the University of Minnesota Medical School in 1992, and he worked there until 2006 when he accepted the position of Senior Director and Head of the Department of Human Genetics at Genentech, Inc. After over a decade at Genentech, Tim became an independent consultant and later accepted his current position at Maze Therapeutics.Tim has received numerous awards and honors over the course of his career, including recognition for one of the Top 10 Advances in Rheumatology in 2003 and 2004 by the Arthritis Foundation, being named the John F. Finn Arthritis Foundation Land Grant Endowed Chair at the University of Minnesota Medical School, as well as receipt of the Edmund L. Dubois Memorial Award for Research in Lupus from the American College of Rheumatology, the Leukemia & Lymphoma Society Scholar Award, the Feltl Family Award for Research in Rheumatic Disease, and other honors. In our interview, Tim shares more about his life and science.

Dr. Paul Changelian is Vice President of Biology at Aclaris Therapeutics and Director of Biology at Confluence Life Sciences. He is working to discover new drugs to treat autoimmune disease and inflammation in conditions like rheumatoid arthritis, ulcerative colitis, Crohn's disease, and multiple sclerosis. In these conditions, the immune system inadvertently attacks cells in your body. He and his team are working to identify and test small molecule drugs that patients could take by pill that would inhibit this abnormal activation of the immune system to slow down damage to joints or other areas that may be under attack. They have also recently begun working on potential cancer treatments that can impact inflammation around tumors to improve the body's ability to clear tumors. Some of Paul's passions outside of science include exercising, walking around in nature, and music. He listens to hard rock and jazz music, and he enjoys playing jazz music on the trumpet. Paul received his B.S. in chemistry from the University of Michigan in Ann Arbor and his Ph.D. in immunology from Harvard University in Cambridge. Afterwards, he conducted postdoctoral research in neurobiology at Washington University in St. Louis. Paul then worked in various roles at Pfizer for about 18 years. He served briefly on the faculty at the University of Michigan in Ann Arbor before becoming Director of Biology at Lycera Corporation. From 2012 - 2014, Paul served as Senior Director of Pharmacology at Infinity Pharmaceuticals before accepting his current positions.

Dr. Verónica Pérez Rodríguez is an Associate Professor of Anthropology at the University at Albany, State University of New York (SUNY). Verónica is an archaeologist and anthropologist who is interested in studying people and life in cities over time. Through her work, she examines how people lived many years ago, what brought them to cities, what made them stay, what were the tradeoffs, and what were the environmental impacts. Her work focuses on the highlands of the Mixteca Alta in the southern Mexican state of Oaxaca. This region was a cradle of urbanism, innovation, and complex societies as early as 300 BC. When she's not working, Verónica loves relaxing at home, watching movies, and hiking with her children and her husband. She also loves running outdoors, knitting, and reading fiction books in her free time. She earned a B.A. in Anthropology as well as a B.A. in Linguistics from the University of Texas at El Paso. Verónica then attended graduate school at the University of Georgia where she was awarded her Ph.D. in Ecological and Environmental Anthropology. She served on the faculty at Northern Arizona University before joining the faculty at the University at Albany, SUNY in 2013. In our interview, Verónica shares more about her life and science.

Dr. R. Douglas Fields is Chief of the Nervous System Development and Plasticity Section at the National Institutes of Health and Adjunct Professor in the Neuroscience and Cognitive Science Program at the University of Maryland, College Park. In addition, Doug is the author of numerous books and magazine articles about the brain, including the recently released book Electric Brain: How the New Science of Brainwaves Reads Minds, Tells Us How We Learn, and Helps Us Change for the Better. Doug studies how the brain develops and the mechanisms involved in changes to the brain's structure and function (plasticity). He is particularly interested in how experience regulates development and plasticity in the brain as well as the mechanisms at a cellular level that are involved in learning. When he's not doing research or writing about science, Doug enjoys rock climbing, mountain climbing, building acoustic guitars, and making his own beer and wine. He received his B.A. in biology from the University of California, Berkeley, his M.A. degree in marine biology from San Jose State University, and his Ph.D. degree in marine biology from the University of California, San Diego, working jointly in the Medical School and Scripps Institution of Oceanography. Afterwards, Doug conducted postdoctoral research at Stanford University, Yale University, and the NIH before starting his research laboratory at the NIH in 1994. Doug is an elected Fellow of the American Association for the Advancement of Science, and he is the Founder and Editor-In-Chief of the scientific journal Neuron Glia Biology. In our interview, Doug tells us more about his life and science.